Showing results (1-10 of 22) with videos related to
Sort By:
Pageof 3
Mayo Clinic Proceedings|January 1, 1982
William Osler and his Gulstonian Lectures on malignant endocarditisR D PruittGastroenterology|September 1, 1976
Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndromeA P Geubel, A H Baggenstoss, W H SummerskillGastroenterology|April 1, 1981
Laboratory assessment of severe chronic active liver disease during and after corticosteroid therapy: correlation of serum transaminase and gamma globulin levels with histologic featuresA J Czaja, A M Wolf, A H BaggenstossThe Journal of Pediatrics|December 1, 1975
Liver dysfunction and histologic abnormalities in neonatal hypopituitarismS P Herman, A H Baggenstoss, M D CloutierMayo Clinic Proceedings|June 1, 1980
Clinical assessment of cirrhosis in severe chronic active liver disease: specificity and sensitivity of physical and laboratory findingsA J Czaja, A M Wolf, A H BaggenstossThe New England Journal of Medicine|January 1, 1981
Corticosteroid-treated chronic active hepatitis in remission: uncertain prognosis of chronic persistent hepatitisA J Czaja, J Ludwig, A H Baggenstoss, et al.Mayo Clinic Proceedings|March 1, 1978
Deferoxamine-chelatable iron in hemochromatosis and other disorders of iron overloadW P Baldus, V F Fairbanks, E R Dickson, et al.Clinical and Experimental Immunology|October 1, 1978
Circulating IgG complexes in primary biliary cirrhosis. A serial study in forty patients followed for two yearsR C Gupta, E R Dickson, F C McDuffie, et al.The American Journal of Medicine|August 1, 1982
Immune complexes in primary biliary cirrhosis. Higher prevalence of circulating immune complexes in patients with associated autoimmune featuresR C Gupta, E R Dickson, F C McDuffie, et al.Mayo Clinic Proceedings|May 1, 1982
Prognostic and therapeutic implications of extreme serum aminotransferase elevation in chronic active hepatitisG L Davis, A J Czaja, A H Baggenstoss, et al.Pageof 3